How should low-threshold and primary care clinics prepare to provide long-acting injectable buprenorphine? A qualitative implementation study of patient and staff perspectives

Imagine the human body as a car that has gotten stuck in a deep, sticky mud pit called addiction. For years, drivers have been trying to pull out using a daily tow rope called sublingual buprenorphine. It works, but it's a hassle: you have to remember to grab the rope every single day, and if you forget, the car sinks back into the mud. Now, scientists have invented a "super-tow" called long-acting injectable buprenorphine (LAIB). Think of this as a giant, powerful winch that, once attached, can pull the car out and keep it safe for a whole month without the driver needing to do anything. This new tool is a game-changer for people with opioid use disorder (OUD), but just like any new piece of heavy machinery, you can't just drop it in a garage and expect it to work. You need the right mechanics, the right tools, and a clear plan to get it running.

This paper is a behind-the-scenes look at how three different clinics in New York City tried to install this "super-tow" for the first time. The researchers didn't just watch the mechanics; they talked to the drivers (patients), the mechanics (doctors and nurses), and the people who run the garage (administrators). They wanted to find out: What makes the engine sputter? What makes it roar? And how do we make sure this new tool actually helps people get out of the mud? The study suggests that while everyone was excited to try the new winch, there were some tricky bumps in the road, like not knowing how to operate the controls or where to store the heavy equipment. But with some teamwork and a few smart adjustments, the clinics figured out how to make it work.

The Mission: Installing the "Super-Tow"

The researchers set up a project in three very different garages: one was a standard primary care clinic (like a general auto shop), and the other two were "low-threshold" clinics run by a syringe services program (think of these as community hubs that offer help without asking for a driver's license or a clean record first). They wanted to see how these places could start offering the monthly injection instead of just the daily pills.

To figure this out, the team didn't just sit in a lab. They went into the field. They held focus groups with 23 staff members and interviewed 15 people with lived experience of opioid use disorder. They also took notes during 12 meetings where the clinic teams brainstormed how to make the new system work. They used a special map called the "CFIR" (which is just a fancy checklist for spotting what helps or hurts when trying something new) to organize their findings.

The Good News: Everyone Wanted to Help

The first thing the researchers found was that the mood was incredibly positive. The staff at both the regular clinic and the community hubs were enthusiastic. They saw the "super-tow" as a great way to give patients more freedom. One staff member at the community hub compared the daily pill to a chore that eats up your time, while the monthly shot felt like getting your time back. "You take that once a month and that's it. You're good," one person said.

The patients, too, were curious. They liked the idea of not having to worry about their medication every single day. They felt that having this option didn't conflict with the "harm reduction" mission of the clinics (which is basically the idea of helping people stay safe and healthy no matter where they are in their journey). They saw it as just another choice, like choosing between different types of fuel.

The Bumps in the Road: What Went Wrong?

However, excitement alone doesn't fix a car. The study found several specific hurdles that needed to be cleared.

1. The Mechanics Didn't Feel Ready
Even though the doctors and nurses were eager, many of them felt a bit shaky about the new tool. The doctors knew the basics but weren't confident enough to explain exactly what a patient would feel or how the withdrawal would work. One doctor admitted, "I feel moderately confident... but there are still questions about patient experience that I wouldn't feel as comfortable telling patients about."

The nurses had their own worries. Some were worried their licenses didn't allow them to give the shot, and others just hadn't been trained on how to do it yet. They wanted to see it done first, then practice under supervision before trying it on their own. Similarly, the harm reduction staff at the community hubs felt they didn't have enough information to answer the tough questions patients might ask, like "Will this stop me from getting high?" or "What happens if I stop taking it?"

2. The "Storage" Problem
Here's a weird rule: because this medicine is a controlled substance, it has to be stored in a very specific, super-secure way, like a vault. The clinics didn't have these vaults at first. One clinic had to borrow a safe spot from a pharmacy, while the others had to buy their own heavy-duty lockboxes. They also had to figure out new ways to order the medicine from special pharmacies and keep track of every single shot given, which was a lot of paperwork.

3. The "Time" Crunch
Doctors are busy. The study found that when a clinic was swamped, it was hard to remember to bring up the new option, let alone explain it in detail. One doctor said, "The reason I didn't bring it up was because the opioid use disorder became like the fourth most important problem... I'm not going to bring it up when there's five other things to talk about." It was easy for the new treatment to get pushed to the bottom of the to-do list.

4. The "Paperwork" Maze
Getting the medicine to the clinic was a puzzle. The medicine had to be shipped to a specific address listed on the doctor's government license. If a doctor worked at two different places but only had one address on their license, the medicine would get stuck. Also, dealing with insurance companies to get permission to use the drug took a lot of time and phone calls.

The Fixes: How They Got It Running

The clinics didn't give up; they adapted. Here is how they solved the problems:

• The "Mentor" System: The clinics leaned heavily on "clinical champions"—usually doctors who specialize in addiction medicine. These experts acted like master mechanics. They taught the other doctors how to talk to patients, helped nurses practice giving the shots, and even stepped in to give the first few shots themselves to show everyone how it's done.
• Better Training: They created special training sessions with videos showing exactly how to give the injection. They also held sessions to explain the rules about storing the medicine so nurses felt safe and legal giving the shots.
• Peer Messengers: The patients said they didn't just want to hear from a doctor; they wanted to hear from someone who had already used the "super-tow." They suggested having a "peer messenger"—someone with lived experience—to share their story. This made the information feel more real and trustworthy.
• Streamlining the Workflow: The clinics figured out better ways to track who needed a shot and when. They set up systems to remind patients and made sure the medicine arrived on time.

What the Patients Wanted to Know

The people with lived experience were very clear about what they needed to know before trying the new treatment. They wanted the nitty-gritty details:

• "Will it really hold me for 30 days, or will I start feeling cravings after two weeks?"
• "What are the side effects, and do they get better after a year?"
• "How do I get off this if I want to stop?"
• "Does it mess with my other meds or my ability to have kids?"

They also wanted to know that the clinic wouldn't force them to switch. They liked the idea that it was a choice, just like the choice to use other services at the clinic.

The Bottom Line

This study suggests that putting long-acting injectable buprenorphine into regular clinics and community hubs is totally doable, but it's not as simple as just handing out the shots. It requires a team effort. You need strong leaders who support the change, experts to teach the staff, and a clear plan for storing and ordering the medicine. Most importantly, you need to listen to the patients and the staff to figure out what they are worried about.

The researchers found that when clinics had a supportive culture, good leadership, and access to addiction experts, they could overcome the barriers. The study doesn't say this is a magic cure-all that solves every problem instantly, but it does show a clear roadmap for how clinics can get ready to offer this powerful new tool. By listening to the people who use the service and the people who provide it, these clinics managed to turn a complex challenge into a working solution that could help more people get out of the mud.